Lv5
1246 积分 2024-08-01 加入
Ponsegromab for the Treatment of Cancer Cachexia
8天前
已完结
Definition and classification of cancer cachexia: an international consensus
8天前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
9天前
已完结
Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer With Brain Metastases
1个月前
已完结
Risk-adaptive Therapy Guided by Dynamic ctDNA in Nasopharyngeal Carcinoma
1个月前
已完结
Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
1个月前
已完结
927MO Osimertinib (osi) before and after chemoradiotherapy (CRT) in patients (pts) with unresectable (UR) stage III EGFRm NSCLC: Phase II NEOLA study interim analysis (IA)
2个月前
已关闭
Inavolisib for PIK3CA-mutant non-small cell lung cancer: A case report
3个月前
已完结
Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective study
4个月前
已完结
A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19)
4个月前
已完结
皖公网安备34019202002308
